GlassScriptPhysician profile
Jamie L Mcqueen
NPI 1952539363
$2,017.04
in general payments reported to CMS, 2019-2025
28 companies · $881 in 2025
The $881 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $224 · 2022: $130 · 2023: $436 · 2024: $347 · 2025: $881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,663.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $238.04 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $223.70 | 2021 | |
| Inari Medical, INC. | $180.38 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bayer Healthcare Pharmaceuticals INC. | $144.57 | 2023 | |
| Evoke Pharma, INC. | $136.49 | 2024 | |
| Amgen INC. | $123.39 | 2025 | Otezla, Repatha, Evenity |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $122.15 | 2023 | Lifevest |
| Medtronic, INC. | $106.79 | 2024-2025 | Symplicity G3, Aquamantys(Tm) |
| Janssen Pharmaceuticals, INC | $99.99 | 2022 | |
| Exact Sciences Corporation | $98.86 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Novo Nordisk INC | $80.97 | 2025 | Rybelsus, Ozempic, Wegovy |
| Aimmune Therapeutics, INC. | $59.64 | 2024-2025 | Zenpep |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.43 | 2025 | Xifaxan |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $46.17 | 2025 | Caplyta |
| Astrazeneca Pharmaceuticals LP | $38.34 | 2025 | Breztri, Airsupra |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $35.76 | 2025 | Xyosted |
| Angiodynamics, INC. | $31.23 | 2023 | Alphavac |
| Cardiovascular Systems INC. | $29.97 | 2022 | |
| Abbott Laboratories | $21.57 | 2023 | Jeti |
| Phadia US INC. | $19.35 | 2025 | Immunocap |
| Otsuka America Pharmaceutical, INC. | $18.01 | 2025 | Rexulti |
| Ibsa Pharma INC. | $17.35 | 2025 | Licart, Flector, Tirosint |
| Lundbeck LLC | $17.11 | 2025 | Rexulti |
| Cordis US Corp. | $15.84 | 2024 | Mynx Control |
| Lilly USA, LLC | $15.39 | 2025 | Mounjaro, Zepbound |
| Abbvie INC. | $14.31 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.24 | 2025 | Trintellix |
| Cardiva Medical, INC. | $14.00 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Mcqueen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.